Steve E. Krognes
2017
In 2017, Steve E. Krognes earned a total compensation of $1.2M as Chief Financial Officer and Treasurer at Denali Therapeutics, a 42% increase compared to previous year.
Compensation breakdown
| Bonus | $218,875 |
|---|---|
| Option Awards | $497,350 |
| Salary | $437,750 |
| Other | $12,585 |
| Total | $1,166,560 |
Krognes received $497.4K in option awards, accounting for 43% of the total pay in 2017.
Krognes also received $218.9K in bonus, $437.8K in salary and $12.6K in other compensation.
Rankings
In 2017, Steve E. Krognes' compensation ranked 8,237th out of 14,666 executives tracked by ExecPay. In other words, Krognes earned more than 43.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,237 out of 14,666 | 44th |
Division Manufacturing | 3,115 out of 5,772 | 46th |
Major group Chemicals And Allied Products | 1,026 out of 2,075 | 51st |
Industry group Drugs | 808 out of 1,731 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 150 out of 313 | 52nd |
Source: SEC filing on April 26, 2018.
Krognes' colleagues
We found three more compensation records of executives who worked with Steve E. Krognes at Denali Therapeutics in 2017.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019